Related references
Note: Only part of the references are listed.Merkel Cell Carcinoma: New Trends
Ellen M. Zwijnenburg et al.
CANCERS (2021)
Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles
Piotr Donizy et al.
CANCERS (2021)
Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes
Satendra Kumar et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The Ubiquitin-Specific Protease Usp7, a Novel Merkel Cell Polyomavirus Large T-Antigen Interaction Partner, Modulates Viral DNA Replication
Manja Czech-Sioli et al.
JOURNAL OF VIROLOGY (2020)
Management Recommendations for Merkel Cell Carcinoma-A Danish Perspective
Simon Naseri et al.
CANCERS (2020)
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
John W. Walker et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
Sandra P. D'Angelo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
Meghan A. Morrissey et al.
IMMUNITY (2020)
Merkel Cell Polyomavirus and Merkel Cell Carcinoma
Valeria Pietropaolo et al.
CANCERS (2020)
Merkel Cell Polyomavirus in Merkel Cell Carcinoma: Integration Sites and Involvement of the KMT2D Tumor Suppressor Gene
Reety Arora et al.
VIRUSES-BASEL (2020)
Positron Emission Tomography in Merkel Cell Carcinoma
Christos Sachpekidis et al.
CANCERS (2020)
TIM3 comes of age as an inhibitory receptor
Yochai Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity
Wei Liu et al.
BIOLOGY-BASEL (2020)
Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation
Prabhakaran Kumar et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Targeting ALK in Cancer: Therapeutic Potential of Proapoptotic Peptides
Arthur Aubry et al.
CANCERS (2019)
Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series
Jaclyn LoPiccolo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA
Lotte Steuten et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2019)
Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
Natalie Longino et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma
Mahtab Samimi et al.
CELLULAR IMMUNOLOGY (2019)
Expression of Notch 3 and Jagged 1 Is Associated With Merkel Cell Polyomavirus Status and Prognosis in Merkel Cell Carcinoma
Lusi Oka Wardhani et al.
ANTICANCER RESEARCH (2019)
ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma
Tuukka Veija et al.
HISTOPATHOLOGY (2019)
Tumour cell-intrinsic CTLA4 regulates PD-L1 expression in non-small cell lung cancer
Huijun Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma
Thibault Kervarrec et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Infectious Entry of Merkel Cell Polyomavirus
Miriam Becker et al.
JOURNAL OF VIROLOGY (2019)
Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response
Donglim Esther Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Global PD-L1 Signals and Tumor-Infiltrating Lymphocytes: Markers of Immunogenicity in Different Subsets of Merkel Cell Carcinoma and Potential Therapeutic Implications
Noreen M. Walsh et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2019)
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
Alessia Villani et al.
DERMATOLOGY AND THERAPY (2019)
Surgical resection improves median overall survival with marginal improvement in long-term survival when compared with definitive radiotherapy in Merkel cell carcinoma: A propensity score matched analysis of the National Cancer Database
G. Paul Wright et al.
AMERICAN JOURNAL OF SURGERY (2018)
The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, UK
S. G. Keohane et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same
A. J. Huq et al.
FAMILIAL CANCER (2018)
MCV-miR-M1 Targets the Host-Cell Immune Response Resulting in the Attenuation of Neutrophil Chemotaxis
Pouria Akhbari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics
Kelly G. Paulson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Adjuvant Radiation Therapy Improves Patient Survival in Early-Stage Merkel Cell Carcinoma: A 15-Year Single-Institution Study
Albert Y. Han et al.
LARYNGOSCOPE (2018)
Characterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1
Celestino Velasquez et al.
FRONTIERS IN MICROBIOLOGY (2018)
Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells
Maria Rita Gaiser et al.
ONCOIMMUNOLOGY (2018)
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma A Preplanned Interim Analysis of a Clinical Trial
Sandra P. D'Angelo et al.
JAMA ONCOLOGY (2018)
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥ 1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Howard L. Kaufman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Hedgehog Signaling Pathway and Autophagy in Cancer
Xian Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab.
Ash Bullement et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358
Suzanne Louise Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
Paul Nghiem et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
K. G. Paulson et al.
NATURE COMMUNICATIONS (2018)
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
Paul W. Harms et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
MCL-1 inhibition in cancer treatment
Weiguo Xiang et al.
ONCOTARGETS AND THERAPY (2018)
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
Natalie J. Miller et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes
Aric . Colunga et al.
CLINICAL CANCER RESEARCH (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
Lack of clinical impact of 18F-fluorodeoxyglucose positron emission tomography with simultaneous computed tomography for stage I and II Merkel cell carcinoma with concurrent sentinel lymph node biopsy staging: A single institutional experience from Westmead Hospital, Sydney
Jui Liu et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2017)
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study
Kelly G. Paulson et al.
CANCER (2017)
Increased expression of EZH2 in Merkel cell carcinoma is associated with disease progression and poorer prognosis
Kelly L. Harms et al.
HUMAN PATHOLOGY (2017)
Association of expression of the hedgehog signal with Merkel cell polyomavirus infection and prognosis of Merkel cell carcinoma
Teruyuki Kuromi et al.
HUMAN PATHOLOGY (2017)
Tricking the balance: NK cells in anti-cancer immunity
Jens Pahl et al.
IMMUNOBIOLOGY (2017)
Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis
Rosa Molfetta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Understanding the Molecular Genetics of Basal Cell Carcinoma
Cristina Pellegrini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
RE: Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
John A. Vargo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting
H. J. Kwun et al.
ONCOGENE (2017)
Protein-mediated viral latency is a novel mechanism for Merkel cell polyomavirus persistence
Hyun Jin Kwun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
Jingwei Cheng et al.
PLOS PATHOGENS (2017)
RE: Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
John A. Vargo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival
Natalie J. Miller et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Merkel cell carcinoma
Juergen C. Becker et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
First-line (1L) avelumab treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Preliminary data from an ongoing study.
Sandra P. D'Angelo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Interaction between Merkel cell carcinoma and the immune system: Pathogenetic and therapeutic implications
Irene Zanetti et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma
C. M. Sauer et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in Merkel cell carcinoma (MCC)
Suzanne L. Topalian et al.
CANCER RESEARCH (2017)
Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
Tuukka Veija et al.
BMC CANCER (2017)
Radiotherapy and Conservative Surgery in the Locoregional Management of Merkel Cell Carcinoma: The British Columbia Cancer Agency Experience
Chris Harrington et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy
Gerald Goh et al.
ONCOTARGET (2016)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma
Tobin Strom et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System
Kelly L. Harms et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma
M. Samimi et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
Wei Liu et al.
CELL HOST & MICROBE (2016)
Rationale for anti-GITR cancer immunotherapy
Deborah A. Knee et al.
EUROPEAN JOURNAL OF CANCER (2016)
A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma
Noreen M. Walsh et al.
HUMAN PATHOLOGY (2016)
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
Shailender Bhatia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L. Kaufman et al.
LANCET ONCOLOGY (2016)
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Ximena Bonilla et al.
NATURE GENETICS (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T. Nghiem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics
Philip R. Cohen et al.
ONCOTARGET (2016)
RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells
Sonja Hesbacher et al.
ONCOTARGET (2016)
Tumor-Suppressor Functions of the TP53 Pathway
Brandon J. Aubrey et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Merkel cell polyomavirus infection and Merkel cell carcinoma
Wei Liu et al.
CURRENT OPINION IN VIROLOGY (2016)
Roles of pRB in the Regulation of Nucleosome and Chromatin Structures
Chiharu Uchida
BIOMED RESEARCH INTERNATIONAL (2016)
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
Shailender Bhatia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma
Cathrin Ritter et al.
SCIENTIFIC REPORTS (2016)
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
Paul William Harms et al.
CANCER RESEARCH (2015)
Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals
Xudong Wu et al.
CELL RESEARCH (2015)
Risk of Merkel Cell Carcinoma After Solid Organ Transplantation
Christina A. Clarke et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The Role of Adjuvant Therapy in the Management of Head and Neck Merkel Cell Carcinoma An Analysis of 4815 Patients
Michelle M. Chen et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2015)
Risk of Merkel Cell Carcinoma After Solid Organ Transplantation
Christina A. Clarke et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Meta-Analysis of DNA Tumor-Viral Integration Site Selection Indicates a Role for Repeats, Gene Expression and Epigenetics
Janet M. Doolittle-Hall et al.
CANCERS (2015)
Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience
Evan Liang et al.
PLOS ONE (2015)
Spontaneous regression of Merkel cell carcinoma: A case report and review of the literature
C. Pang et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2015)
Bmi-1: At the crossroads of physiological and pathological biology
Resham Bhattacharya et al.
GENES & DISEASES (2015)
RB1 gene in Merkel cell carcinoma: hypermethylation in all tumors and concurrent heterozygous deletions in the polyomavirus-negative subgroup
Helka Sahi et al.
APMIS (2014)
T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
Rikke Lyngaa et al.
CLINICAL CANCER RESEARCH (2014)
MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma
Hong Xie et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Seroprevalence Rates of BKV, JCV, and MCPyV Polyomaviruses in the General Czech Republic Population
Vojtech Sroller et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
High-Affinity Rb Binding, p53 Inhibition, Subcellular Localization, and Transformation by Wild-Type or Tumor-Derived Shortened Merkel Cell Polyomavirus Large T Antigens
Sophie Borchert et al.
JOURNAL OF VIROLOGY (2014)
Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma
Patrick J. Cimino et al.
MODERN PATHOLOGY (2014)
The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma
Christian Adam et al.
PLOS ONE (2014)
Seroprevalence of Merkel Cell Polyomavirus in the General Rural Population of Anyang, China
Chanyuan Zhang et al.
PLOS ONE (2014)
The important role of radiation treatment in the management of Merkel cell carcinoma
G. Hruby et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Merkel Cell Polyomavirus Small T Antigen Controls Viral Replication and Oncoprotein Expression by Targeting the Cellular Ubiquitin Ligase SCFFbw7
Hyun Jin Kwun et al.
CELL HOST & MICROBE (2013)
Age-Specific Seroprevalences of Merkel Cell Polyomavirus, Human Polyomaviruses 6, 7, and 9, and Trichodysplasia Spinulosa-Associated Polyomavirus
Jerome T. J. Nicol et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
Olga K. Afanasiev et al.
CLINICAL CANCER RESEARCH (2013)
Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings
Claire Martel-Jantin et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Mechanisms of p53 Restriction in Merkel Cell Carcinoma Cells Are Independent of the Merkel Cell Polyoma Virus T Antigens
Roland Houben et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses
Mitra Dowlatshahi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Merkel Cell Polyomavirus Large T Antigen Has Growth-Promoting and Inhibitory Activities
Jingwei Cheng et al.
JOURNAL OF VIROLOGY (2013)
Merkel Cell Polyomavirus Small T Antigen Targets the NEMO Adaptor Protein To Disrupt Inflammatory Signaling
David A. Griffiths et al.
JOURNAL OF VIROLOGY (2013)
The T Antigen Locus of Merkel Cell Polyomavirus Downregulates Human Toll-Like Receptor 9 Expression
Naveed Shahzad et al.
JOURNAL OF VIROLOGY (2013)
KIT gene mutation analysis in solid tumours: biology, clincial applications and trends in diagnostic reporting
Clifton Ming Tay et al.
PATHOLOGY (2013)
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Mario Henrique M. Barros et al.
PLOS ONE (2013)
Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential
Megan E. Spurgeon et al.
VIROLOGY (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options
Laura Desch et al.
JOURNAL OF SKIN CANCER (2013)
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
Esdy N. Rozali et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Merkel cell carcinoma: Identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data
Valerie A. Smith et al.
LARYNGOSCOPE (2012)
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion
Manu Rangachari et al.
NATURE MEDICINE (2012)
Differentiation and gene expression profile of tumor-associated macrophages
Astrid Schmieder et al.
SEMINARS IN CANCER BIOLOGY (2012)
Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus
Helka Sahi et al.
VIRCHOWS ARCHIV (2012)
Structures of Merkel Cell Polyomavirus VP1 Complexes Define a Sialic Acid Binding Site Required for Infection
Ursula Neu et al.
PLOS PATHOGENS (2012)
Histological, Immunohistological, and Clinical Features of Merkel Cell Carcinoma in Correlation to Merkel Cell Polyomavirus Status
T. Jaeger et al.
JOURNAL OF SKIN CANCER (2012)
Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood
Jayasri G. Iyer et al.
CLINICAL CANCER RESEARCH (2011)
Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Harri Sihto et al.
CLINICAL CANCER RESEARCH (2011)
Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma
Marika Waltari et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Masahiro Shuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
Kelly G. Paulson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
High Levels of Antibodies Against Merkel Cell Polyomavirus Identify a Subset of Patients With Merkel Cell Carcinoma With Better Clinical Outcome
Antoine Touze et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Serological evidence of Merkel cell polyomavirus primary infections in childhood
Tingting Chen et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
Judong Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer
Shailender Bhatia et al.
CURRENT ONCOLOGY REPORTS (2011)
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Michael Croft
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients
Kelly G. Paulson et al.
CANCER RESEARCH (2010)
EXPRESSION OF HEDGEHOG SIGNALING MOLECULES IN MERKEL CELL CARCINOMA
Markus Brunner et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status
Aleodor A. Andea et al.
HUMAN PATHOLOGY (2010)
Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission
Myriam Loyo et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
EFFECT OF RADIOTHERAPY DOSE AND VOLUME ON RELAPSE IN MERKEL CELL CANCER OF THE SKIN
Matthew Foote et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Merkel Cell Carcinoma: Incidence, Mortality, and Risk of Other Cancers
Jeanette Kaae et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Signaling Through OX40 Enhances Antitumor Immunity
Shawn M. Jensen et al.
SEMINARS IN ONCOLOGY (2010)
Structural evaluation of new human polyomaviruses provides clues to pathobiology
Edward M. Johnson
TRENDS IN MICROBIOLOGY (2010)
Distinct Merkel Cell Polyomavirus Molecular Features in Tumour and Non Tumour Specimens from Patients with Merkel Cell Carcinoma
Helene C. Laude et al.
PLOS PATHOGENS (2010)
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Patrick S. Moore et al.
NATURE REVIEWS CANCER (2010)
Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma
V. Koljonen et al.
BRITISH JOURNAL OF CANCER (2009)
Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Y. Katoh et al.
CURRENT MOLECULAR MEDICINE (2009)
Molecular Mechanisms of IFN-gamma to Up-Regulate MHC Class I Antigen Processing and Presentation
Fang Zhou
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2009)
Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc
Kelly G. Paulson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma
Harri Sihto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Association of Merkel Cell Polyomavirus-Specific Antibodies With Merkel Cell Carcinoma
Joseph J. Carter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Expression of Notch-1 and alteration of the E-cadherin/β-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma)
John Panelos et al.
MODERN PATHOLOGY (2009)
Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression
Gil Ju Seo et al.
VIROLOGY (2009)
Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
Diana V. Pastrana et al.
PLOS PATHOGENS (2009)
The Role of OX40-Mediated Co-stimulation in T-Cell Activation and Survival
William L. Redmond et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
Vascular density has prognostic value in Merkel cell carcinoma
Lydia Ng et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2008)
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
Brian T. Fife et al.
IMMUNOLOGICAL REVIEWS (2008)
p14ARF hypermethylation is common but INK4a-ARF locus or p53 mutations are rare in Merkel cell carcinoma
Anita Lassacher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients:: the AEIOU features
Michelle Heath et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Expression of VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma
Markus Brunner et al.
MODERN PATHOLOGY (2008)
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
A. M. Krieg
ONCOGENE (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma:: implications for tyrosine kinase-based tumorigenesis
Reena V. Kartha et al.
MODERN PATHOLOGY (2008)
Post-immune UV irradiation induces Tr1-like regulatory T cells that suppress humoral immune responses
Linan Wang et al.
INTERNATIONAL IMMUNOLOGY (2008)
Merkel cell carcinoma frequently shows histologic features of basal cell carcinoma: a study of 30 cases
Nigel J. Ball et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Patched1 regulates Hedgehog signaling at the primary cilium
Rajat Rohatgi et al.
SCIENCE (2007)
Merkel cell carcinoma adjuvant therapy: Current data support radiation but not chemotherapy
Kelly M. Garneski et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Expression profiles associated with aggressive behavior in Merkel cell carcinoma
Maria-Teresa Fernandez-Figueras et al.
MODERN PATHOLOGY (2007)
Targeting OX40 and OX40L for the treatment of Autoimmunity and cancer
William L. Redmond et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2007)
The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation
Andrew E. Gelman et al.
IMMUNITY (2006)
Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma - The Dana-Farber experience and meta-analysis of the literature
Sheela G. Gupta et al.
ARCHIVES OF DERMATOLOGY (2006)
Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF
S Nakae et al.
JOURNAL OF IMMUNOLOGY (2006)
Does chemotherapy improve survival in high-risk Stage I and II Merkel cell carcinoma of the skin?
MG Poulsen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
E Contardi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand
T Ito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Molecular aetiology and pathogenesis of basal cell carcinoma
CMLJ Tilli et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion
JX Song et al.
IMMUNITY (2005)
Merkel cell carcinoma: Prognosis and treatment of patients from a single institution
PJ Allen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Recurrent DNA copy number changes revealed by comparative genomic hybridization in primary Merkel cell carcinomas
ML Larramendy et al.
MODERN PATHOLOGY (2004)
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
LP Chen
NATURE REVIEWS IMMUNOLOGY (2004)
Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: A possible role in asthma?
JK Burgess et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells
G Regl et al.
ONCOGENE (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions
A Zingoni et al.
JOURNAL OF IMMUNOLOGY (2004)
Toll-like receptors stimulate human neutrophil function
F Hayashi et al.
BLOOD (2003)
High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group Study - TROG 96 : 07
M Poulsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of merkel and skin squamous cell carcinomas
S Popp et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance
J Shimizu et al.
NATURE IMMUNOLOGY (2002)
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells
PR Rogers et al.
IMMUNITY (2001)
Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma
M Van Gele et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Multimodality treatment of Merkel cell carcinoma: Case series and literature review of 1024 cases
H Medina-Franco et al.
ANNALS OF SURGICAL ONCOLOGY (2001)
Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: Case series and review of 204 cases
PTH Tai et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
